Companies: 10,795·Total market cap: $144.5T
Elia Group SA/NV

Elia Group SA/NV

ELIAFOTCUtilities● Active
$104.79
$-37.32(-26.26%)
Market Cap$11.4B
P/E Ratio
52W High$142.11
52W Low$104.79
Overview

Elia Group SA/NV (ELIAF) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · ELIAF · as of 2026-06-09

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$4.44B$3.77B$3.84B$3.62B$2.55B
Cost of Revenue$3.11B$2.09B$2.30B$3.40B$2.25B
Gross Profit$1.33B$1.67B$1.55B$0.21B$0.30B
Gross Margin %(computed)29.88%44.39%40.26%5.88%11.95%
Operating Expenses
R&D Expenses$0.00B$0.00B$0.04B$0.03B$0.02B
G&A Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
Total Operating Expenses($0.26B)$0.79B$0.90B$0.43B$0.53B
Operating Income$1.59B$0.88B$0.64B$0.56B$0.49B
Operating Margin %(computed)35.77%23.34%16.76%15.48%19.23%
Interest Income$0.17B$0.10B$0.06B$0.00B$0.00B
Interest Expense$0.36B$0.28B$0.18B$0.12B$0.11B
Income Before Tax$0.87B$0.74B$0.56B$0.56B$0.43B
Income Tax Expense$0.18B$0.23B$0.16B$0.15B$0.11B
Net Income$0.59B$0.45B$0.36B$0.36B$0.30B
Net Margin %(computed)13.19%11.96%9.25%9.98%11.57%
Per Share & EBITDA
EPS (Basic)$5.56$5.43$4.42$4.80$4.00
Wtd Avg Shares0.10B0.08B0.07B0.07B0.07B
EBITDA$2.33B$1.55B$1.29B$1.15B$0.77B
EBITDA Margin %(computed)52.46%41.03%33.66%31.78%30.04%

Data source: Financial Modeling Prep · Last updated: 2026-06-09 · EUR · B

Explore more Elia Group SA/NV data

About Elia Group SA/NV (ELIAF) Income Statement

Elia Group SA/NV (ELIAF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ELIAF reported revenue of $4.44B, gross profit of $1.33B (gross margin 29.88%), and net income of $0.59B — a net profit margin of 13.19%.

Frequently asked questions

ELIAF · 4 questions

Elia Group SA/NV (ELIAF) reported revenue of $4.44B for 2025, up 17.9% year-over-year.

ELIAF revenueELIAF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09